CVS Health began administering COVID-19 vaccines in long-term care facilities
On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…
On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…
On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…
On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…
On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyメs Investigational New Drug (IND)…
On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyメs Investigational New Drug (IND)…
On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpル At-Home COVID-19 Collection Kit is…
On Dec. 21, 2020, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Dec. 21, 2020, Pfizer and BioNTech announced that the European Commission (EC) had granted a conditional marketing…
On Dec. 21, 2020, OraSure Technologies disclosed that the FDA had requested additional information as part of its…
On Dec. 1, 2020, the governmenrt of Singapore announced that it had given U.S. start-up Eat Just the…
On Dec. 18, 2020, the World Health Organization (WHO) announced that it had arrangements in place to access…
On Dec. 18, 2020, Johnson & Johnson announced that its subsidiary Janssen Pharma, will provide up to 500…
On Dec. 18, 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System,…
On Dec. 18, 2020, tthe U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult…
On Dec. 17, 2020, NIAID announced that two randomized, controlled Phase 3 clinical trials had begun evaluating investigational…
On Dec. 17, 2020, NIAID announced that an observational study had launched to evaluate the short- and long-term…
On Dec. 17, 2020, ACON Laboratories announced that its SARS-COV-2 IgG/IgM Rapid Test has been authorized for emergency…
On Dec. 17, 2020, XPhyto Therapeutics and 3a-diagnostics announced the successful validation of their point-of-care SARS-CoV-2 (COVID-19) RT-PCR…
On Dec. 17, 2020, JAMA reported that the daily U.S. mortality rate for COVID-19 deaths was equivalent to…
On Dec. 17, 2020, Quest Diagnostics and The Commons Project, a non-profit public trust dedicated to building and…
On Dec. 17, 2020, PRA Health Sciences announced the enhancement of its COVID-19 Monitoring Program with the addition…
On Dec. 17, 2020, Johnson & Johnson announced that the large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) of…
On Dec. 17, 2020, Regeneron announced that the New England Journal of Medicine (NEJM) had published initial clinical…
On Dec. 16, 2020, National Institute of Allergy and Infectious Diseases reported that an observational study had launched…
On Dec. 16, 2020, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for…
On Dec. 16, 2020, Heat Biologics announced it had completed its gp96-based COVID-19 vaccine cell line, which is…
On Dec. 16, 2020, Pacific Biosciences announced initial findings from the companyメs research collaboration with Labcorp that was…
On Dec. 16, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced an agreement to supply Mainland China with an…
On Dec. 16, 2020, Meridian Bioscience announced that it had been awarded funding in the amount of approximately…
On Dec. 16, 2020, Abbott announced that the FDA had issued Emergency Use Authorization (EUA) for virtually guided…